Nicolas Levoin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Venues

Nature chemical biology

European journal of immunology

Cell death & disease

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Eden Lebrault, Christelle Oblet, Keerthi Kurma, Nicolas Levoin, Robin Jeannet, Mickael Jean, Pierre Vacher, Patrick Legembre
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and non-apoptotic pathways. European journal of immunology (2023)
Shoji F Kenji, Keerthi Kurma, Brigitte Collet, Christelle Oblet, Laure Debure, Carmelo Di Primo, Laëtitia Minder, Franck Vérité, Yannic Danger, Mickael Jean, Aubin Penna, Nicolas Levoin, Patrick Legembre
MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways. Cell death & disease 13 (10) (2022)
Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, Nangunoori Sampath Kumar, Hélène Solhi, Rémy Le Guevel, Blandine Baratte, Thomas Robert, Sandrine Ruchaud, Stéphane Bach, Surender Singh Jadav, Chada Raji Reddy, Paul Mosset, Nicolas Gouault, Nicolas Levoin, René Grée
Structure Activity Relationship Studies around DB18 , a Potent and Selective Inhibitor of CLK Kinases. Molecules (Basel, Switzerland) 27 (19) (2022)
Amanda Poissonnier, Jean-Philippe Guégan, Ha Thanh Nguyen, Daniel Best, Nicolas Levoin, Guennadi Kozlov, Kalle Gehring, Raphael Pineau, Florence Jouan, Lucie Morere, Sophie Martin, Mélissa Thomas, Estibaliz Lazaro, Isabelle Douchet, Thomas Ducret, Pierre van de Weghe, Patrick Blanco, Mickael Jean, Pierre Vacher, Patrick Legembre
Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammation. Nature chemical biology 14 (12) (2018)

Nicolas Levoin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Levoin